Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

Similar articles for PubMed (Select 21666721)

1.

Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer.

Coombs GS, Schmitt AA, Canning CA, Alok A, Low IC, Banerjee N, Kaur S, Utomo V, Jones CM, Pervaiz S, Toone EJ, Virshup DM.

Oncogene. 2012 Jan 12;31(2):213-25. doi: 10.1038/onc.2011.228. Epub 2011 Jun 13.

2.

Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.

Song S, Christova T, Perusini S, Alizadeh S, Bao RY, Miller BW, Hurren R, Jitkova Y, Gronda M, Isaac M, Joseph B, Subramaniam R, Aman A, Chau A, Hogge DE, Weir SJ, Kasper J, Schimmer AD, Al-awar R, Wrana JL, Attisano L.

Cancer Res. 2011 Dec 15;71(24):7628-39. doi: 10.1158/0008-5472.CAN-11-2745. Epub 2011 Oct 18.

3.

A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.

Prosperi JR, Goss KH.

Curr Drug Targets. 2010 Sep;11(9):1074-88. Review.

PMID:
20545611
4.

Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades.

Katoh M, Katoh M.

Cancer Biol Ther. 2006 Sep;5(9):1059-64. Epub 2006 Sep 4. Review.

PMID:
16940750
5.

Targeting the Wnt/β-catenin signaling pathway in human cancers.

Yao H, Ashihara E, Maekawa T.

Expert Opin Ther Targets. 2011 Jul;15(7):873-87. doi: 10.1517/14728222.2011.577418. Epub 2011 Apr 12. Review.

PMID:
21486121
6.

Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.

Kang DW, Lee SH, Yoon JW, Park WS, Choi KY, Min do S.

Cancer Res. 2010 May 15;70(10):4233-42. doi: 10.1158/0008-5472.CAN-09-3470. Epub 2010 May 4.

7.

MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors.

Teissedre B, Pinderhughes A, Incassati A, Hatsell SJ, Hiremath M, Cowin P.

PLoS One. 2009;4(2):e4537. doi: 10.1371/journal.pone.0004537. Epub 2009 Feb 19. Erratum in: PLoS ONE. 2009;4(3). doi: 10.1371/annotation/3706d475-e082-4be6-b328-7d8aea02b986.

8.

Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.

Ettenberg SA, Charlat O, Daley MP, Liu S, Vincent KJ, Stuart DD, Schuller AG, Yuan J, Ospina B, Green J, Yu Q, Walsh R, Li S, Schmitz R, Heine H, Bilic S, Ostrom L, Mosher R, Hartlepp KF, Zhu Z, Fawell S, Yao YM, Stover D, Finan PM, Porter JA, Sellers WR, Klagge IM, Cong F.

Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15473-8. doi: 10.1073/pnas.1007428107. Epub 2010 Aug 16.

9.
10.

Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.

Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A, Anant S, Queimado L.

Oncogene. 2012 May 31;31(22):2725-37. doi: 10.1038/onc.2011.455. Epub 2011 Oct 17.

PMID:
22002305
11.

Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.

Hallett RM, Kondratyev MK, Giacomelli AO, Nixon AM, Girgis-Gabardo A, Ilieva D, Hassell JA.

PLoS One. 2012;7(3):e33976. doi: 10.1371/journal.pone.0033976. Epub 2012 Mar 28.

12.

The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.

Chen HJ, Hsu LS, Shia YT, Lin MW, Lin CM.

Biochem Pharmacol. 2012 Nov 1;84(9):1143-53. doi: 10.1016/j.bcp.2012.08.011. Epub 2012 Aug 19.

PMID:
22935447
13.

Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.

Lavergne E, Hendaoui I, Coulouarn C, Ribault C, Leseur J, Eliat PA, Mebarki S, Corlu A, Clément B, Musso O.

Oncogene. 2011 Jan 27;30(4):423-33. doi: 10.1038/onc.2010.432. Epub 2010 Sep 20.

14.
15.

A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis.

Wang W, Liu H, Wang S, Hao X, Li L.

Cell Res. 2011 May;21(5):730-40. doi: 10.1038/cr.2011.30. Epub 2011 Feb 15.

16.

The Wnt-β-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion.

Cai WY, Wei TZ, Luo QC, Wu QW, Liu QF, Yang M, Ye GD, Wu JF, Chen YY, Sun GB, Liu YJ, Zhao WX, Zhang ZM, Li BA.

J Cell Sci. 2013 Jul 1;126(Pt 13):2877-89. doi: 10.1242/jcs.123810. Epub 2013 Apr 23.

17.

A role for iron in Wnt signalling.

Brookes MJ, Boult J, Roberts K, Cooper BT, Hotchin NA, Matthews G, Iqbal T, Tselepis C.

Oncogene. 2008 Feb 7;27(7):966-75. Epub 2007 Aug 13.

PMID:
17700530
18.

Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.

Matsuzaki E, Takahashi-Yanaga F, Miwa Y, Hirata M, Watanabe Y, Sato N, Morimoto S, Hirofuji T, Maeda K, Sasaguri T.

J Bone Miner Res. 2006 Aug;21(8):1307-16.

PMID:
16869729
19.

Nanosecond pulsed electric field inhibits cancer growth followed by alteration in expressions of NF-κB and Wnt/β-catenin signaling molecules.

Ren Z, Chen X, Cui G, Yin S, Chen L, Jiang J, Hu Z, Xie H, Zheng S, Zhou L.

PLoS One. 2013 Sep 17;8(9):e74322. doi: 10.1371/journal.pone.0074322. eCollection 2013.

20.

Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.

Jiang YG, Luo Y, He DL, Li X, Zhang LL, Peng T, Li MC, Lin YH.

Int J Urol. 2007 Nov;14(11):1034-9.

PMID:
17956532
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk